Tompkins Financial Corp Bristol Myers Squibb CO Transaction History

Tompkins Financial Corp

$1.07 Billion
Q2 2025

A detailed history of Tompkins Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tompkins Financial Corp holds 5,708 shares of BMY stock, worth $265,707. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,708

Previous 9,151 37.62%

Holding current value

$265,707

Previous $558,000 52.69%

% of portfolio

0.02%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	SELL	$44.12 - $59.6 $151,905 - $205,202	-3,443 Reduced 37.62%	5,708 $264,000
Q1 2025 Apr 07, 2025	BUY	$53.9 - $63.11 $12,127 - $14,199	225 Added 2.52%	9,151 $558,000
Q4 2024 Jan 15, 2025	SELL	$51.92 - $59.94 $8,307 - $9,590	-160 Reduced 1.76%	8,926 $504,000
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $41,920 - $54,699	-1,057 Reduced 10.42%	9,086 $470,000
Q2 2024 Jul 17, 2024	SELL	$40.25 - $52.99 $81,345 - $107,092	-2,021 Reduced 16.61%	10,143 $421,000
Q1 2024 Apr 08, 2024	BUY	$47.98 - $54.4 $15,593 - $17,680	325 Added 2.75%	12,164 $659,000
Q4 2023 Jan 08, 2024	BUY	$48.48 - $57.85 $65,835 - $78,560	1,358 Added 12.96%	11,839 $607,000
Q3 2023 Nov 20, 2023	SELL	$57.89 - $64.73 $67,557 - $75,539	-1,167 Reduced 10.02%	10,481 $608,000
Q2 2023 Jul 12, 2023	SELL	$63.71 - $70.74 $28,669 - $31,832	-450 Reduced 3.72%	11,648 $744,000
Q1 2023 Apr 20, 2023	SELL	$65.71 - $74.53 $195,618 - $221,875	-2,977 Reduced 19.75%	12,098 $838,000
Q4 2022 Jan 06, 2023	BUY	$68.48 - $81.09 $14,586 - $17,272	213 Added 1.43%	15,075 $1.09 Million
Q2 2022 Jul 14, 2022	SELL	$72.62 - $79.98 $29,048 - $31,992	-400 Reduced 2.62%	14,862 $1.15 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $285,328 - $342,134	4,641 Added 43.7%	15,262 $1.12 Million
Q4 2021 Jan 24, 2022	BUY	$53.63 - $62.52 $43,976 - $51,266	820 Added 8.37%	10,621 $662,000
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $32,839 - $38,467	-555 Reduced 5.36%	9,801 $580,000
Q1 2021 Jun 09, 2021	SELL	$59.34 - $66.74 $14,300 - $16,084	-241 Reduced 2.27%	10,356 $654,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $6.53 Million - $7.4 Million	-113,169 Reduced 91.44%	10,597 $657,000
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $6.44 Million - $7.3 Million	111,568 Added 914.64%	123,766 $6.9 Million
Q3 2020 Oct 23, 2020	SELL	$57.43 - $63.64 $46,460 - $51,484	-809 Reduced 6.22%	12,198 $735,000
Q2 2020 Jul 29, 2020	SELL	$54.82 - $64.09 $29,054 - $33,967	-530 Reduced 3.92%	13,007 $765,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $4,222 - $6,136	-91 Reduced 0.67%	13,537 $755,000
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $447,761 - $584,064	9,099 Added 200.91%	13,628 $875,000
Q3 2019 Oct 17, 2019	BUY	$42.77 - $50.71 $4,277 - $5,071	100 Added 2.26%	4,529 $229,000
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $53,900 - $59,602	-1,208 Reduced 21.43%	4,429 $201,000
Q1 2019 Apr 30, 2019	BUY	$45.12 - $53.8 $2,526 - $3,012	56 Added 1.0%	5,637 $269,000
Q1 2019 Apr 17, 2019	SELL	$45.12 - $53.8 $9,024 - $10,760	-200 Reduced 3.46%	5,581 $347,000
Q4 2018 Jan 22, 2019	BUY	$48.76 - $63.23 $9,752 - $12,646	200 Added 3.58%	5,781 $300,000
Q3 2018 Oct 18, 2018	SELL	$55.19 - $62.25 $55 - $62	-1 Reduced 0.02%	5,581 $347,000
Q1 2018 Apr 26, 2018	SELL	$59.92 - $68.98 $30,978 - $35,662	-517 Reduced 8.48%	5,582 $353,000
Q4 2017 Jan 24, 2018	BUY	$59.94 - $65.35 $68,691 - $74,891	1,146 Added 23.14%	6,099 $374,000
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $273,554 - $315,704	4,953	4,953 $315,000

Others Institutions Holding BMY

# of Institutions

2,665

Shares Held

1.6B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.

Account

Tompkins Financial Corp Bristol Myers Squibb CO Transaction History